Sustainable Plastics 4 MedTech

Start | Projects | Sustainable Plastics 4 MedTech

Sustainable Plastics 4 MedTech (SuPlaMed)

Now Available: White Paper on Bioplastics in Medical Technology

Read our white paper featuring insights from industry, research, and our network: White Paper (PDF)

The Cluster Medizintechnik and the Cluster industrielle Biotechnologie are working together with their networks in the SuPlaMed cross-cluster project to analyze the potential of bioplastics for more sustainable medical technology and at the same time to develop ways to achieve greater independence from international supply chains.

Activities

Determining the challenges and obstacles to implementing bioplastics in the healthcare industry
Surveying users, manufacturers and universities/research institutions
Identifying potentials and solutions

Goal

The objective of the cross-cluster project is the cooperation of the cluster offices with their partners in order to identify potential for the sustainable substitution of plastics in medical technology. The focus is on identifying economically viable, technically feasible and regulatory feasible alternatives such as bioplastics. In addition, the project identifies R&D project ideas and forms suitable project consortia to drive forward the implementation of these approaches.

Key Findings

Medical technology is facing a real tradeoff: the highest safety standards on one side and growing pressure to become more sustainable on the other. This is exactly where the white paper—one of the outcomes of the Cross-Cluster project SuPlaMed—comes in.

It shows where the industry truly stands today: many companies already recognize the importance of the issue, yet clear regulatory frameworks, economic incentives, and practical solutions are often still missing.

To address this, we brought together perspectives from industry, research, and our network. The result is an honest look at: